Journal des maladies infectieuses et de la médecine

Recent years have witnessed the emergence of several novel infectious diseases, posing significant challenges to public health worldwide. This article reviews the latest developments in antiviral therapies to combat these emerging infectious diseases. We discuss the key antiviral strategies, including small molecule inhibitors, monoclonal antibodies, and nucleic acid-based therapies, and their applications in managing outbreaks. These advances in antiviral therapies offer promising tools to address the evolving landscape of infectious diseases.

Immunotherapeutic approaches have emerged as a promising strategy for controlling infectious diseases. This article provides an overview of various immunotherapeutic strategies, including vaccines, monoclonal antibodies, and immune checkpoint inhibitors, in the context of infectious disease control. We explore the mechanisms underlying these approaches, their applications, and their potential to address current and emerging infectious threats.

Vaccine development has entered a new era, marked by unprecedented advances in technology and a profound impact on infectious disease prevention. This article reviews the latest innovations in vaccine design, development, and delivery methods, focusing on their application to target a wide range of infectious diseases. These breakthroughs offer promising avenues for improving global public health by preventing and controlling infectious diseases.

Antibiotic resistance in bacterial pathogens is a pressing global health concern. This comprehensive review delves into the intricate mechanisms underlying bacterial resistance to antibiotics. We explore various resistance strategies employed by bacteria, including genetic mutations, horizontal gene transfer, efflux pumps, and biofilm formation. Understanding these mechanisms is crucial in the development of new therapeutic approaches and the preservation of antibiotic efficacy.